Indcon Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-05-2024
- Paid Up Capital ₹ 0.96 M
as on 19-05-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 104.24%
(FY 2020)
- Profit 123.88%
(FY 2020)
- Ebitda -109.40%
(FY 2020)
- Net Worth 128.14%
(FY 2020)
- Total Assets 53.13%
(FY 2020)
About Indcon Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M, as per Ministry of Corporate Affairs (MCA) records.
Divya Misra, Usha Misra, and Prabhas Misra serve as directors at the Company.
- CIN/LLPIN
U85110DL2002PLC114517
- Company No.
114517
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indcon Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Misra  | Director | 09-Sep-2009 | Current |
| Usha Misra | Director | 08-Mar-2002 | Current |
| Prabhas Misra | Director | 08-Mar-2002 | Current |
Financial Performance of Indcon Pharma.
Indcon Pharma Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 104.24% increase. The company also saw a substantial improvement in profitability, with a 123.88% increase in profit. The company's net worth Soared by an impressive increase of 128.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indcon Pharma?
Unlock access to Indcon Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Psa Air Products (India) Private LimitedActive 8 months 21 daysUsha Misra and Prabhas Misra are mutual person
- Fgd Engineering Private LimitedActive 15 years 10 months
Usha Misra and Prabhas Misra are mutual person
- Sanjivani Associates Private Ltd.Active 38 years 6 days
Usha Misra and Prabhas Misra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indcon Pharma?
Unlock and access historical data on people associated with Indcon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indcon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indcon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
